
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (22): 2769-2775.DOI: 10.12114/j.issn.1007-9572.2024.0401
Special Issue: 高血压最新文章合辑; 家庭医生签约最新文章合辑; 老年人群健康最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2024-09-10
Revised:2024-10-15
Published:2025-08-05
Online:2025-06-30
Contact:
GUO Zhinan
通讯作者:
郭志南
作者简介:作者贡献:
陈友兰、郭志南负责文章的构思与设计;陈友兰、蓝彦琦进行文章的可行性分析;吴阿华、张海霞、黄健康负责文献检索、数据收集和整理;陈友兰负责论文撰写,进行结果的分析与解释,对文章整体负责;郭志南负责文章的质量控制、审校修订、监督管理。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0401
| 年龄 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||
|---|---|---|---|---|---|---|
| 男 | 女 | 合计 | 男 | 女 | 合计 | |
| 65~69岁 | 2 610(17.22) | 3 448(22.75) | 6 058(39.98) | 1 320(14.94) | 1 770(20.03) | 3 090(34.96) |
| 70~74岁 | 1 787(11.79) | 2 541(16.77) | 4 328(28.56) | 1 192(13.49) | 1 347(13.47) | 2 539(28.73) |
| 75~79岁 | 1 131(7.46) | 1 557(10.27) | 2 688(17.74) | 808(9.14) | 843(9.54) | 1 651(18.68) |
| 80~84岁 | 584(3.85) | 780(5.15) | 1 364(9.00) | 442(5.00) | 496(5.61) | 938(10.61) |
| 85~89岁 | 236(1.56) | 349(2.30) | 585(3.86) | 192(2.17) | 272(3.08) | 464(5.25) |
| ≥90岁 | 48(0.32) | 83(0.55) | 131(0.86) | 65(0.74) | 91(1.03) | 156(1.77) |
| 合计 | 6 396(42.21) | 8 758(57.79) | 15 154(100.00) | 4 019(45.47) | 4 819(54.53) | 8 838(100.00) |
Table 1 The gender and age distribution of hypertensive patients aged 65 and above between the signed and unsigned groups
| 年龄 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||
|---|---|---|---|---|---|---|
| 男 | 女 | 合计 | 男 | 女 | 合计 | |
| 65~69岁 | 2 610(17.22) | 3 448(22.75) | 6 058(39.98) | 1 320(14.94) | 1 770(20.03) | 3 090(34.96) |
| 70~74岁 | 1 787(11.79) | 2 541(16.77) | 4 328(28.56) | 1 192(13.49) | 1 347(13.47) | 2 539(28.73) |
| 75~79岁 | 1 131(7.46) | 1 557(10.27) | 2 688(17.74) | 808(9.14) | 843(9.54) | 1 651(18.68) |
| 80~84岁 | 584(3.85) | 780(5.15) | 1 364(9.00) | 442(5.00) | 496(5.61) | 938(10.61) |
| 85~89岁 | 236(1.56) | 349(2.30) | 585(3.86) | 192(2.17) | 272(3.08) | 464(5.25) |
| ≥90岁 | 48(0.32) | 83(0.55) | 131(0.86) | 65(0.74) | 91(1.03) | 156(1.77) |
| 合计 | 6 396(42.21) | 8 758(57.79) | 15 154(100.00) | 4 019(45.47) | 4 819(54.53) | 8 838(100.00) |
| 组别 | 例数 | 2021年 | 2023年 | χ2值 | P值 |
|---|---|---|---|---|---|
| 签约组 | 15 154 | 9 108(60.10) | 11 635(76.78) | 6.697 | 0.010 |
| 未签约组 | 8 838 | 5 501(62.24) | 6 064(68.61) | 1.084 | 0.298 |
| χ2值 | 0.084 | 1.624 | |||
| P值 | 0.772 | 0.203 |
Table 2 Blood pressure control status of signed and unsigned groups
| 组别 | 例数 | 2021年 | 2023年 | χ2值 | P值 |
|---|---|---|---|---|---|
| 签约组 | 15 154 | 9 108(60.10) | 11 635(76.78) | 6.697 | 0.010 |
| 未签约组 | 8 838 | 5 501(62.24) | 6 064(68.61) | 1.084 | 0.298 |
| χ2值 | 0.084 | 1.624 | |||
| P值 | 0.772 | 0.203 |
| 组别 | 例数 | 左侧舒张压 | 左侧收缩压 | 右侧舒张压 | 右侧收缩压 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | ||
| 签约组 | 15 154 | 80±10 | 78±8a | 1(-5,7) | 134±18 | 136±16a | 0(-2,6) | 81±10 | 79±9a | 0(-1,2) | 138±15 | 132±20a | 0(-1,7) |
| 未签约组 | 8 838 | 81±10 | 79±9a | 0(-5,5) | 138±16 | 139±18a | 1(-6,9) | 82±10 | 80±9a | 0(-5,6) | 138±16 | 137±16a | -1(-9,9) |
| u值 | — | — | -4.254 | — | — | -1.684 | — | — | -0.866 | — | — | -17.168 | |
| P值 | — | — | <0.001 | — | — | 0.092 | — | — | 0.387 | — | — | <0.001 | |
Table 3 Blood pressure measurement of signed and unsigned groups
| 组别 | 例数 | 左侧舒张压 | 左侧收缩压 | 右侧舒张压 | 右侧收缩压 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | 2021年( | 2023年( | 差值[M(P25,P75)] | ||
| 签约组 | 15 154 | 80±10 | 78±8a | 1(-5,7) | 134±18 | 136±16a | 0(-2,6) | 81±10 | 79±9a | 0(-1,2) | 138±15 | 132±20a | 0(-1,7) |
| 未签约组 | 8 838 | 81±10 | 79±9a | 0(-5,5) | 138±16 | 139±18a | 1(-6,9) | 82±10 | 80±9a | 0(-5,6) | 138±16 | 137±16a | -1(-9,9) |
| u值 | — | — | -4.254 | — | — | -1.684 | — | — | -0.866 | — | — | -17.168 | |
| P值 | — | — | <0.001 | — | — | 0.092 | — | — | 0.387 | — | — | <0.001 | |
| 项目 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||||
|---|---|---|---|---|---|---|---|---|
| 2021年 | 2023年 | χ2值 | P值 | 2021年 | 2023年 | χ2值 | P值 | |
| BMI | 4.537 | 0.033 | 0.080 | 0.777 | ||||
| <18.5 kg/m2 | 309(2.04) | 333(2.20) | 226(2.56) | 263(2.98) | ||||
| 18.5~<24.0 kg/m2 | 7 110(46.92) | 9 343(61.65) | 4 161(47.08) | 4 293(48.57) | ||||
| 24.0~<28.0 kg/m2 | 5 729(37.81) | 4 057(26.77) | 3 422(38.72) | 3 450(39.04) | ||||
| ≥28.0 kg/m2 | 2 006(13.24) | 1 421(9.38) | 1 029(11.64) | 832(9.41) | ||||
| 中心性肥胖 | 11 565(76.32) | 9 598(63.34) | 3.986 | 0.046 | 6 772(76.62) | 6 754(76.42)a | 0.028 | 0.868 |
| 空腹血糖偏高 | 5 618(37.07) | 1 918(12.66) | 15.360 | <0.001 | 3 076(34.80) | 1 883(21.31) | 4.861 | 0.027 |
| 糖尿病患者空腹血糖偏高 | 2 749(54.96) | 1 395(27.89) | 15.014 | <0.001 | 1 166(52.22) | 872(39.05) | 3.408 | 0.055 |
| 非糖尿病患者空腹血糖偏高 | 2 869(28.26) | 523(5.15) | 19.198 | <0.001 | 1 910(28.92) | 1 011(15.31) | 5.711 | 0.017 |
| 血脂异常 | 11 541(76.16) | 11 257(74.28) | 0.107 | 0.744 | 6 669(75.46) | 6 789(76.82) | 0.110 | 0.741 |
| 肝功能异常 | 2 756(18.19) | 2 698(17.80) | 0.001 | 0.999 | 1 635(18.50) | 1 465(16.58) | 0.112 | 0.738 |
| 肾功能异常 | 6 734(44.44) | 6 234(41.16) | 0.184 | 0.668 | 4 010(45.37) | 3 484(39.42) | 0.739 | 0.390 |
| 血常规异常 | 2 076(13.70) | 1 691(11.16) | 0.411 | 0.521 | 1 189(13.45) | 1 037(11.73) | 0.046 | 0.831 |
| 尿常规异常 | 6 693(44.17) | 5 686(37.52) | 0.744 | 0.388 | 3 594(40.67) | 3 189(36.08) | 0.528 | 0.467 |
| 心电图检查异常 | 8 525(56.26) | 4 957(32.71) | 10.710 | 0.001 | 5 087(56.98) | 4 437(50.20)a | 0.985 | 0.321 |
| B超检查异常 | 9 148(60.37) | 8 287(54.69) | 0.512 | 0.474 | 5 387(60.95) | 4 785(54.14) | 1.003 | 0.317 |
Table 4 Health examination results of signed and unsigned groups
| 项目 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||||
|---|---|---|---|---|---|---|---|---|
| 2021年 | 2023年 | χ2值 | P值 | 2021年 | 2023年 | χ2值 | P值 | |
| BMI | 4.537 | 0.033 | 0.080 | 0.777 | ||||
| <18.5 kg/m2 | 309(2.04) | 333(2.20) | 226(2.56) | 263(2.98) | ||||
| 18.5~<24.0 kg/m2 | 7 110(46.92) | 9 343(61.65) | 4 161(47.08) | 4 293(48.57) | ||||
| 24.0~<28.0 kg/m2 | 5 729(37.81) | 4 057(26.77) | 3 422(38.72) | 3 450(39.04) | ||||
| ≥28.0 kg/m2 | 2 006(13.24) | 1 421(9.38) | 1 029(11.64) | 832(9.41) | ||||
| 中心性肥胖 | 11 565(76.32) | 9 598(63.34) | 3.986 | 0.046 | 6 772(76.62) | 6 754(76.42)a | 0.028 | 0.868 |
| 空腹血糖偏高 | 5 618(37.07) | 1 918(12.66) | 15.360 | <0.001 | 3 076(34.80) | 1 883(21.31) | 4.861 | 0.027 |
| 糖尿病患者空腹血糖偏高 | 2 749(54.96) | 1 395(27.89) | 15.014 | <0.001 | 1 166(52.22) | 872(39.05) | 3.408 | 0.055 |
| 非糖尿病患者空腹血糖偏高 | 2 869(28.26) | 523(5.15) | 19.198 | <0.001 | 1 910(28.92) | 1 011(15.31) | 5.711 | 0.017 |
| 血脂异常 | 11 541(76.16) | 11 257(74.28) | 0.107 | 0.744 | 6 669(75.46) | 6 789(76.82) | 0.110 | 0.741 |
| 肝功能异常 | 2 756(18.19) | 2 698(17.80) | 0.001 | 0.999 | 1 635(18.50) | 1 465(16.58) | 0.112 | 0.738 |
| 肾功能异常 | 6 734(44.44) | 6 234(41.16) | 0.184 | 0.668 | 4 010(45.37) | 3 484(39.42) | 0.739 | 0.390 |
| 血常规异常 | 2 076(13.70) | 1 691(11.16) | 0.411 | 0.521 | 1 189(13.45) | 1 037(11.73) | 0.046 | 0.831 |
| 尿常规异常 | 6 693(44.17) | 5 686(37.52) | 0.744 | 0.388 | 3 594(40.67) | 3 189(36.08) | 0.528 | 0.467 |
| 心电图检查异常 | 8 525(56.26) | 4 957(32.71) | 10.710 | 0.001 | 5 087(56.98) | 4 437(50.20)a | 0.985 | 0.321 |
| B超检查异常 | 9 148(60.37) | 8 287(54.69) | 0.512 | 0.474 | 5 387(60.95) | 4 785(54.14) | 1.003 | 0.317 |
| 项目 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||||
|---|---|---|---|---|---|---|---|---|
| 2021年 | 2023年 | χ2值 | P值 | 2021年 | 2023年 | χ2值 | P值 | |
| 吸烟情况 | 0.043 | 0.979 | 0.001 | 0.999 | ||||
| 从不吸烟 | 12 177(80.36) | 12 304(81.19) | 7 145(80.84) | 7 185(81.30) | ||||
| 吸烟 | 2 073(13.68) | 2 000(13.20) | 1 173(13.27) | 1 159(13.11) | ||||
| 已戒烟 | 904(5.96) | 850(5.61) | 520(5.88) | 494(5.59) | ||||
| 饮酒情况 | 0.084 | 0.994 | 0.072 | 0.995 | ||||
| 从不 | 13 224(87.26) | 13 441(88.70) | 7 767(87.88) | 7 824(88.53) | ||||
| 经常 | 1 223(8.07) | 1 021(6.74) | 687(7.77) | 603(6.82) | ||||
| 每天 | 418(2.76) | 456(3.01) | 255(2.89) | 284(3.21) | ||||
| 偶尔 | 289(1.91) | 236(1.56) | 129(1.46) | 127(1.44) | ||||
| 运动情况 | 10.026 | 0.018 | 1.076 | 0.783 | ||||
| 每天 | 6 233(41.13) | 9 435(62.26) | 3 659(41.40) | 4 196(47.48) | ||||
| 不锻炼 | 4 639(30.61) | 2 379(15.70) | 2 681(30.33) | 2 125(24.04) | ||||
| 每周≥3次 | 2 534(16.72) | 1 973(13.02) | 1 432(16.20) | 1 425(16.21) | ||||
| 偶尔 | 1 748(11.53) | 1 367(9.02) | 1 066(12.06) | 1 092(12.36) | ||||
| 服药依从性 | 8.962 | 0.011 | 1.151 | 0.562 | ||||
| 规律 | 10 190(67.24) | 12 708(83.86) | 5 892(66.67) | 6 438(72.84) | ||||
| 间断 | 2 578(17.01) | 1 670(11.02) | 1 436(16.25) | 1 350(15.27) | ||||
| 不服药 | 2 386(15.75) | 776(5.12) | 1 510(17.09) | 1 050(11.88) | ||||
Table 5 Lifestyle and medication adherence between signed and unsigned groups
| 项目 | 签约组(n=15 154) | 未签约组(n=8 838) | ||||||
|---|---|---|---|---|---|---|---|---|
| 2021年 | 2023年 | χ2值 | P值 | 2021年 | 2023年 | χ2值 | P值 | |
| 吸烟情况 | 0.043 | 0.979 | 0.001 | 0.999 | ||||
| 从不吸烟 | 12 177(80.36) | 12 304(81.19) | 7 145(80.84) | 7 185(81.30) | ||||
| 吸烟 | 2 073(13.68) | 2 000(13.20) | 1 173(13.27) | 1 159(13.11) | ||||
| 已戒烟 | 904(5.96) | 850(5.61) | 520(5.88) | 494(5.59) | ||||
| 饮酒情况 | 0.084 | 0.994 | 0.072 | 0.995 | ||||
| 从不 | 13 224(87.26) | 13 441(88.70) | 7 767(87.88) | 7 824(88.53) | ||||
| 经常 | 1 223(8.07) | 1 021(6.74) | 687(7.77) | 603(6.82) | ||||
| 每天 | 418(2.76) | 456(3.01) | 255(2.89) | 284(3.21) | ||||
| 偶尔 | 289(1.91) | 236(1.56) | 129(1.46) | 127(1.44) | ||||
| 运动情况 | 10.026 | 0.018 | 1.076 | 0.783 | ||||
| 每天 | 6 233(41.13) | 9 435(62.26) | 3 659(41.40) | 4 196(47.48) | ||||
| 不锻炼 | 4 639(30.61) | 2 379(15.70) | 2 681(30.33) | 2 125(24.04) | ||||
| 每周≥3次 | 2 534(16.72) | 1 973(13.02) | 1 432(16.20) | 1 425(16.21) | ||||
| 偶尔 | 1 748(11.53) | 1 367(9.02) | 1 066(12.06) | 1 092(12.36) | ||||
| 服药依从性 | 8.962 | 0.011 | 1.151 | 0.562 | ||||
| 规律 | 10 190(67.24) | 12 708(83.86) | 5 892(66.67) | 6 438(72.84) | ||||
| 间断 | 2 578(17.01) | 1 670(11.02) | 1 436(16.25) | 1 350(15.27) | ||||
| 不服药 | 2 386(15.75) | 776(5.12) | 1 510(17.09) | 1 050(11.88) | ||||
| 自变量 | b | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| 签约家庭医生(以否为参照) | |||||
| 是 | 0.486 | 0.029 | 288.669 | <0.001 | 1.625(1.536~1.719) |
| 性别(以男为参照) | |||||
| 女 | 0.012 | 0.028 | 0.182 | 0.670 | 1.012(0.957~1.070) |
| 年龄(以65~69岁为参照) | 23.450 | <0.001 | |||
| 70~74岁 | -0.359 | 0.132 | 7.400 | 0.007 | 0.699(0.540~0.905) |
| 75~79岁 | -0.252 | 0.132 | 3.613 | 0.057 | 0.778(0.600~1.008) |
| 80~84岁 | -0.267 | 0.134 | 3.984 | 0.046 | 0.766(0.590~0.995) |
| 85~89岁 | -0.260 | 0.137 | 3.612 | 0.057 | 0.771(0.590~1.008) |
| ≥90岁 | -0.122 | 0.145 | 0.702 | 0.402 | 0.885(0.666~1.177) |
| 婚姻状况(以已婚为参照) | |||||
| 未婚/丧偶/离异 | -0.070 | 0.044 | 2.518 | 0.113 | 0.932(0.854~1.017) |
| BMI(以<18.5 kg/m2为参照) | 2.975 | 0.395 | |||
| 18.5~<24.0 kg/m2 | -0.017 | 0.101 | 2.842 | 0.092 | 0.844(0.693~1.028) |
| 24.0~<28.0 kg/m2 | -0.032 | 0.049 | 0.434 | 0.510 | 0.968(0.880~1.066) |
| ≥28.0 kg/m2 | -0.040 | 0.050 | 0.630 | 0.427 | 0.961(0.871~1.060) |
| 中心性肥胖(以否为参照) | |||||
| 是 | -0.137 | 0.033 | 17.644 | <0.001 | 0.872(0.818~0.930) |
| 空腹血糖偏高(以否为参照) | |||||
| 是 | -0.249 | 0.030 | 68.491 | <0.001 | 0.780(0.735~0.827) |
| 血脂异常(以否为参照) | |||||
| 是 | -0.034 | 0.032 | 1.111 | 0.292 | 0.967(0.908~1.029) |
| 肝功异常(以否为参照) | |||||
| 是 | -0.004 | 0.036 | 0.014 | 0.906 | 0.996(0.928~1.069) |
| 肾功异常(以否为参照) | |||||
| 是 | 0.061 | 0.028 | 4.829 | 0.028 | 1.063(1.007~1.123) |
| 血常规异常(以否为参照) | |||||
| 是 | 0.006 | 0.041 | 0.019 | 0.890 | 1.006(0.927~1.091) |
| 尿常规异常(以否为参照) | |||||
| 是 | -0.011 | 0.028 | 0.144 | 0.705 | 0.989(0.936~1.046) |
| 心电图检查异常(以否为参照) | |||||
| 是 | -0.006 | 0.028 | 0.053 | 0.818 | 0.994(0.941~1.046) |
| B超检查异常(以否为参照) | |||||
| 是 | -0.025 | 0.028 | 0.786 | 0.375 | 0.976(0.924~1.030) |
| 吸烟情况(以从不吸烟/已戒烟为参照) | |||||
| 吸烟 | 0.020 | 0.043 | 0.207 | 0.649 | 1.020(0.937~1.110) |
| 饮酒情况(以从不饮酒为参照) | |||||
| 偶尔/经常/每天 | 0.027 | 0.046 | 0.342 | 0.559 | 1.027(0.939~1.125) |
| 运动锻炼(以不锻炼为参照) | 3.464 | 0.325 | |||
| 偶尔 | 0.036 | 0.037 | 0.969 | 0.325 | 1.037(0.965~1.115) |
| 每周≥1次 | 0.031 | 0.047 | 0.447 | 0.504 | 1.032(0.942~1.130) |
| 每天 | 0.071 | 0.041 | 3.036 | 0.081 | 1.074(0.991~1.164) |
| 服药依从性(以不服药为参照) | 2.117 | 0.347 | |||
| 间断 | 0.010 | 0.042 | 0.054 | 0.817 | 1.010(0.931~1.096) |
| 规律 | 0.076 | 0.052 | 2.114 | 0.146 | 1.079(0.974~1.196) |
| 常量 | 0.819 | 0.148 | 30.777 | <0.001 | 2.268 |
Table 6 Multivariate Logistic regression analysis of the impact of family doctor contracted services on blood pressure control in elderly patients with hypertension
| 自变量 | b | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| 签约家庭医生(以否为参照) | |||||
| 是 | 0.486 | 0.029 | 288.669 | <0.001 | 1.625(1.536~1.719) |
| 性别(以男为参照) | |||||
| 女 | 0.012 | 0.028 | 0.182 | 0.670 | 1.012(0.957~1.070) |
| 年龄(以65~69岁为参照) | 23.450 | <0.001 | |||
| 70~74岁 | -0.359 | 0.132 | 7.400 | 0.007 | 0.699(0.540~0.905) |
| 75~79岁 | -0.252 | 0.132 | 3.613 | 0.057 | 0.778(0.600~1.008) |
| 80~84岁 | -0.267 | 0.134 | 3.984 | 0.046 | 0.766(0.590~0.995) |
| 85~89岁 | -0.260 | 0.137 | 3.612 | 0.057 | 0.771(0.590~1.008) |
| ≥90岁 | -0.122 | 0.145 | 0.702 | 0.402 | 0.885(0.666~1.177) |
| 婚姻状况(以已婚为参照) | |||||
| 未婚/丧偶/离异 | -0.070 | 0.044 | 2.518 | 0.113 | 0.932(0.854~1.017) |
| BMI(以<18.5 kg/m2为参照) | 2.975 | 0.395 | |||
| 18.5~<24.0 kg/m2 | -0.017 | 0.101 | 2.842 | 0.092 | 0.844(0.693~1.028) |
| 24.0~<28.0 kg/m2 | -0.032 | 0.049 | 0.434 | 0.510 | 0.968(0.880~1.066) |
| ≥28.0 kg/m2 | -0.040 | 0.050 | 0.630 | 0.427 | 0.961(0.871~1.060) |
| 中心性肥胖(以否为参照) | |||||
| 是 | -0.137 | 0.033 | 17.644 | <0.001 | 0.872(0.818~0.930) |
| 空腹血糖偏高(以否为参照) | |||||
| 是 | -0.249 | 0.030 | 68.491 | <0.001 | 0.780(0.735~0.827) |
| 血脂异常(以否为参照) | |||||
| 是 | -0.034 | 0.032 | 1.111 | 0.292 | 0.967(0.908~1.029) |
| 肝功异常(以否为参照) | |||||
| 是 | -0.004 | 0.036 | 0.014 | 0.906 | 0.996(0.928~1.069) |
| 肾功异常(以否为参照) | |||||
| 是 | 0.061 | 0.028 | 4.829 | 0.028 | 1.063(1.007~1.123) |
| 血常规异常(以否为参照) | |||||
| 是 | 0.006 | 0.041 | 0.019 | 0.890 | 1.006(0.927~1.091) |
| 尿常规异常(以否为参照) | |||||
| 是 | -0.011 | 0.028 | 0.144 | 0.705 | 0.989(0.936~1.046) |
| 心电图检查异常(以否为参照) | |||||
| 是 | -0.006 | 0.028 | 0.053 | 0.818 | 0.994(0.941~1.046) |
| B超检查异常(以否为参照) | |||||
| 是 | -0.025 | 0.028 | 0.786 | 0.375 | 0.976(0.924~1.030) |
| 吸烟情况(以从不吸烟/已戒烟为参照) | |||||
| 吸烟 | 0.020 | 0.043 | 0.207 | 0.649 | 1.020(0.937~1.110) |
| 饮酒情况(以从不饮酒为参照) | |||||
| 偶尔/经常/每天 | 0.027 | 0.046 | 0.342 | 0.559 | 1.027(0.939~1.125) |
| 运动锻炼(以不锻炼为参照) | 3.464 | 0.325 | |||
| 偶尔 | 0.036 | 0.037 | 0.969 | 0.325 | 1.037(0.965~1.115) |
| 每周≥1次 | 0.031 | 0.047 | 0.447 | 0.504 | 1.032(0.942~1.130) |
| 每天 | 0.071 | 0.041 | 3.036 | 0.081 | 1.074(0.991~1.164) |
| 服药依从性(以不服药为参照) | 2.117 | 0.347 | |||
| 间断 | 0.010 | 0.042 | 0.054 | 0.817 | 1.010(0.931~1.096) |
| 规律 | 0.076 | 0.052 | 2.114 | 0.146 | 1.079(0.974~1.196) |
| 常量 | 0.819 | 0.148 | 30.777 | <0.001 | 2.268 |
| [1] |
朱平. 老年人高血压的特点及诊疗进展[J]. 中华老年心脑血管病杂志,2021,23(8):785-787.
|
| [2] |
范雷,梁森,戚敏杰,等. 河南省监测点高血压和糖尿病患者经济负担调查[J]. 中国慢性病预防与控制,2021,29(8):635-638. DOI:10.16386/j.cjpccd.issn.1004-6194.2021.08.018.
|
| [3] |
国家基本公共卫生服务项目基层高血压管理办公室、基层高血压管理专家委员会. 国家基层高血压防治管理指南[J]. 中国循环杂志,2017,32(11):1041-1048.
|
| [4] |
王显君,唐智友,杨文梅,等. 基层医疗卫生机构医防"五融合"健康管理服务模式研究[J]. 中国全科医学,2020,23(31):3924-3929. DOI:10.12114/j.issn.1007-9572.2020.00.454.
|
| [5] |
刘远立. 健康中国建设研究报告2023[M]. 北京:社会科学文献出版社,2023.
|
| [6] |
国家卫生计生委关于印发《国家基本公共卫生服务规范(第三版)》的通知[A/OL]. (2017-02-28)[2024-10-01].
|
| [7] |
李惠梅,常峪文. 体检报告解读与健康指导[M]. 北京:中国医药科技出版社,2018.
|
| [8] |
陈友兰,吴阿华,娄群,等. 2022年厦门市≥65岁老年人健康体检结果分析[J]. 中国初级卫生保健,2023,37(12):13-17.
|
| [9] |
宋建玲,饶志伟,韩魁,等. 家庭医生-专家"双签约"模式在社区老年慢病患者管理中的应用[J]. 老年医学与保健,2021,27(6):1319-1322.
|
| [10] |
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志,2021,36(6):521-545.
|
| [11] |
王琦,杜文雯,宋晓昀,等. 中国成人体质指数轨迹与高血压及血压水平关系[J]. 卫生研究,2023,52(3):354-361.
|
| [12] |
梦宇,连隽,廖子锐,等. 国家基本公共卫生服务老年人健康体检的异常检出率分析[J]. 中国全科医学,2023,26(22):2756-2762. DOI:10.12114/j.issn.1007-9572.2022.0831.
|
| [13] |
胡承伟,吴玉苗,华志佳,等. 上海市长征镇社区空巢高血压老人血压控制情况及影响因素分析[J]. 中国全科医学,2020,23(s2):53-56.
|
| [14] |
欧阳斌发,赵丹,朱利清,等. 社区高血压健康管理患者药物治疗效果分析[J]. 华南预防医学,2022,48(7):803-807.
|
| [15] |
宋建玲,饶志伟,韩魁,等. 家庭医生-专家"双签约"模式在社区老年慢病患者管理中的应用[J]. 老年医学与保健,2021,27(6):1319-1322.
|
| [16] |
高宇,李迈. 健康管理新模式对北京天桥社区居家老人慢性病管理的效果分析[J]. 中国社区医师,2022,38(7):140-142.
|
| [17] |
王爽. 河北省沧州市沧县老年高血压患者健康管理效果及影响因素研究[D]. 北京:中国医学科学院,2023.
|
| [1] | ZHOU Xiaoya, WANG Weikai, LIU Qian, LI Jianhua, SUN Bo, WANG Yanxia. Study of the Interaction between Sleep Quality and Melatonin Receptor 1B Gene Polymorphism on Gestational Hypertension [J]. Chinese General Practice, 2026, 29(21): 2975-2981. |
| [2] | LI Zhenyu, ZHU Qiong, CHEN Rong, LU Jing, YU Zhijie, SHEN Fulai, SHEN Yi, FENG Yu, LIU Mei. A Single-group Community Intervention Trial on Improving the Service Efficiency of Contracted Residents Via an Enhanced Medical-preventive "Micro" Integration Service Package [J]. Chinese General Practice, 2026, 29(21): 3020-3027. |
| [3] | LI Wenping, CHEN Jianhua, XU Jiapei, JIN Xue, PAN Zihan, CHI Chunhua. A Scoping Review on the Empowerment of Community Elderly Health Services by Digital-Intelligent Health Management Platforms [J]. Chinese General Practice, 2026, 29(21): 2938-2949. |
| [4] | YU Haiyan, XIANG Tong, GAO Wenjuan, WU Hao. Research and Application of Digital Health Technologies in Multimorbidity Management [J]. Chinese General Practice, 2026, 29(21): 2933-2937. |
| [5] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [6] | LI Wanyu, JIN Hua, YANG Sen, FU Qiangqiang, YU Dehua. Assessment and Optimization of Community Health Behaviors Guided by the Behaviour Change Wheel Theory [J]. Chinese General Practice, 2026, 29(19): 2688-2694. |
| [7] | ZHANG Xiaojuan, LIU Yang, PENG Bo, YE Yuan, ZHU Kun. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital [J]. Chinese General Practice, 2026, 29(19): 2614-2620. |
| [8] | ZHAO Xinran, WU Yibo, ZHANG Xuxi, CHEN Ping, SUN Xinying. The Current Situation and Influencing Factors of Smart Health Management Services and Devices Utilization among Chinese Adults: a Mixed Methods Study [J]. Chinese General Practice, 2026, 29(19): 2724-2734. |
| [9] | PANG Shu, SUN ying, JIANG Chunyan. Comparison of the Effectiveness of Fried's Frailty Phenotype and the FRAIL Scale in Assessing Pre-frailty among Community-dwelling Older Adults Undergoing Health Examinations [J]. Chinese General Practice, 2026, 29(19): 2664-2670. |
| [10] | ZHAO Xinxin, SUN Xiaoting, LUO Xinhao, SUN Jin, PENG Derong, ZHENG Jialin. Research on the Localization of the Patient-centered Medical Home Model in China: Adaptation Mechanisms, Challenges, and Pathway Analysis [J]. Chinese General Practice, 2026, 29(19): 2608-2613. |
| [11] | MIAO Jingjie, ZHANG Jinwen, WU Qianhao, HAN Peipei. Research Advances on the Effects of Intermittent Fasting on Cardiometabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2538-2545. |
| [12] | CHEN Yan, SHEN Dequan, SHENG Renlei, CHANG Yujie, YANG Jiaqi, DING Jie, SUN Zhifang, WANG Dahui. Influencing Factors and Importance Ranking of the Utilization of Primary-level Traditional Chinese Medicine Preventive and Health Care Services for the Elderly [J]. Chinese General Practice, 2026, 29(16): 2182-2189. |
| [13] | CHEN Bihua, LIN Qiyi, LI Wuhua, SU Jin, TU Liping, SHI Lan, DING Xiaoqin, YI Chuntao. The Influencing Factors and Mechanisms of the Work Output Level of Family Doctor Teams from the Perspective of Team Effectiveness [J]. Chinese General Practice, 2026, 29(16): 2167-2173. |
| [14] | FU Mingyuan, YU Xiaoyi, GE Caiying, KONG Min. Impaired Awareness of Hypoglycemia: Prevalence and Determinants among Community-based Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(16): 2252-2258. |
| [15] | ZHENG Zelu, ZHOU Jun, LIANG Zhi, WANG Xuehui, XU Feng, LI Oujing, XIAO Hong, LIU Xiaoyu, YANG Qingmei, ZHANG Mei, LIN Na, MI Baohong, CHEN Weiheng. Comorbidity Profiles and Treatment Patterns of Osteoarthritis Patients: a Cross-sectional Study Based on Community Medical Records [J]. Chinese General Practice, 2026, 29(16): 2205-2213. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||